From: Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
No. of patients
46
No. ATP-TCA directed courses
56
CR
12
(21%)
PR
21
(38%)
SD
6
(11%)
PD
15
(27%)
No. of patients not evaluable for response
2
(4%)
ORR
33
(59%)
Median PFS (months)
6.6
Median OAS (months)
10.4